-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

605. Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases: Poster III

Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases Program: Oral and Poster Abstracts
Type: Poster
Monday, December 7, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Jan Styczynski1, Beata Kurylo-Rafinska1*, Malgorzata Kubicka1*, Beata Kolodziej1*, Monika Pogorzala1*, Krzysztof Czyzewski1*, Robert Debski1*, Magdalena Wisniewska1*, Mariusz Wysocki1*, Michal Matysiak, Prof., MD PhD2*, Iwona Malinowska3*, Walentyna Balwierz, Prof MD PhD4*, Edyta Juraszewska5*, Jacek Wachowiak6*, Benigna Konatkowska6*, Mariola Woszczyk, MD PhD7*, Igor Olejnik, MD8*, Maryna Krawczuk-Rybak, Prof MD PhD9*, Marta Kuzmicz10*, Jerzy Kowalczyk, Prof MD PhD11*, Maria Jolanta Stefaniak, MD, PhD12*, Wanda Badowska13*, Tomasz Szczepanski, Prof MD, PhD14, Renata Tomaszewska15*, Elzbieta Adamkiewicz-Drozynska16*, Lucyna Maciejka-Kemblowska16*, Grazyna Sobol17*, Agnieszka Mizia-Malarz17* and Joanna Szczepanek18*

1Department of Pediatric Hematology and Oncology, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland
2Department of Pediatrics, Hematology and Oncology, Medical University of Warsaw, Warsaw, Poland
3Department of Pediatric Hematology and Oncology, Medical University Warsaw, Warsaw, Poland
4Department of Pediatric Oncology and Hematology, Jagiellonian University Medical College,, Krakow, Poland
5Department of Pediatric Oncology and Hematology, Jagiellonian University Medical College, Krakow, Krakow, Poland
6Department of Pediatric Hematology, Oncology and Transplantology, University of Medical Sciences, Poznan, Poznan, Poland
7Department of Pediatric Hematology and Oncology, Pediatric Center, Chorzow, Poland
8Department of Pediatric Hematology and Oncology, Pediatric Center Chorzow, Chorzow, Poland
9Department of Pediatric Hematology and Oncology, Medical University, Bialystok, Poland
10Department of Pediatric Hematology and Oncology, Medical University Bialystok, Bialystok, Poland
11Department of Pediatric Hematology, Oncology and Transplantology, Medical University, Lublin, Poland
12Department of Pediatric Hematology, Oncology and Transplantology, Medical University Lublin, Lublin, Poland
13Department of Pediatric Hematology and Oncology, Children Hospital Olsztyn, Olsztyn, Poland
14Department of Pediatric Hematology and Oncology, Medical University of Silesia, Zabrze, Poland
15Department of Pediatric Hematology and Oncology, Medical University of Silesia, Zabrze, Zabrze, Poland
16Department of Pediatric Hematology and Oncology, Medical University Gdansk, Gdansk, Poland
17Department of Pediatrics, Medical University of Silesia, Katowice, Katowice, Poland
18Centre for Modern Interdisciplinary Technologies, Department of Plant Physiology and Biotechnology, Nicolaus Copernicus University, Torun, Torun, Poland

Stacey Tannheimer, PhD*, Jia Liu, Ph.D.*, Rick Sorensen, BS*, Anella Yahiaoui, BS*, Sarah Meadows*, Li Li, PhD, Peng Yue, PhD*, Kathleen S Keegan, Ph.D.*, Jamie Bates, Ph.D.*, Daniel Tumas, PhD, DVM* and Christophe Queva, PhD

Gilead Sciences, Foster City, CA

Luke Fostvedt1*, A. Douglas Laird1*, Jean-Claude Marshall2*, Sherry Li3* and Joseph P. Boni, PhD, BS4*

1Pfizer Inc, La Jolla, CA
2Pfizer Inc, Groton, CT
3Pfizer Inc, Shanghai, China
4Pfizer Inc, Collegeville, PA

Ida Franiak-Pietryga, Ph.D.1*, Henryk Maciejewski, Ph.D.2*, Barbara Ziemba, Ph.D.3*, Dietmar Appelhans, Ph.D.4*, Brigitte Voit, Professor4*, Malgorzata Misiewicz, Ph.D.5*, Tadeusz Robak, MD, Professor6, Jacek Trelinski, MD, Professor7*, Maria Bryszewska, Professor3* and Maciej Borowiec, Professor1*

1Department of Clinical and Laboratory Genetics, Medical University, Lodz, Poland
2Institute of Computer Engineering, Control and Robotics I-6, Wroclaw University of Technology, Wroclaw, Poland
3Department of General Biophysics, University of Lodz, Lodz, Poland
4Leibniz Institute of Polymer Research, Dresden, Germany
5Department of Hematology, Medical University, Lodz, Poland
6Department of Hematology, Medical University of Lodz and Copernicus Memorial Hospital, Lodz, Poland
7Department of Hematology, Medical UniversityUniversity, Lodz, Poland

Yoko Kado, BS1,2*, Fumiaki Kitazawa, MS1*, Masayuki Tsujimoto, PhD3*, Shin-ichi Fuchida, MD, PhD4*, Akira Okano, MD, PhD4*, Mayumi Hatsuse, MD4*, Satoshi Murakami, MD4*, Kumi Ueda, BS1*, Takatoshi Kokufu, BS1*, Shoichi Ozawa3*, Natsuko Ito3*, Satoe Morishita3*, Tetsuya Takada, BS2*, Tetsuya Minegaki, PhD3*, Kohshi Nishiguchi, PhD3*, Eishi Ashihara, MD, PhD2 and Chihiro Shimazaki, MD, PhD4

1Department of Pharmacy, Japan Community Health care Organization Kyoto Kuramaguchi Medical Center, Kyoto, Japan
2Department of Clinical and Translational Physiology, Kyoto Pharmaceutical University, Kyoto, Japan
3Department of Clinical Pharmacy, Kyoto Pharmaceutical University, Kyoto, Japan
4Department of Hematology, Japan Community Health care Organization Kyoto Kuramaguchi Medical Center, Kyoto, Japan

Hideki Goto, MD, PhD1,2*, Rachel Wilkie Grantham, PhD1*, Motoaki Mizuuchi3*, Tetsuji Yamaguchi3*, Takanori Teshima, MD, PhD2, John C. Reed, MD, PhD1 and Shu-ichi Matsuzawa, PhD1*

1Sanford-Burnham-Prebys Medical Discovery Institute, La Jolla, CA
2Department of Hematology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
3JSR micro Inc., La Jolla, CA

Monica Mead, MD, BS1*, Erika Von Euw, PhD, BS2*, Dylan Conklin2*, Ben Powell, PhD, BS3*, Kanthinh Manivong, BS2*, Eileen Do4*, Dennis J. Slamon, MD, PhD5* and Sarah Larson, MD6

1UCLA Medical Center, Los Angeles, CA
2Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA
3Plexxikon, Berkley, CA
4NYP, Weill Cornell Medical Center, New York, NY
5Division of Hematology/Oncology, Department of Medicine, UCLA, Los Angeles, CA
6University of California, Los Angeles, CA

Luigi Scotto, PhD1*, Xavier Jirau-Serrano, BS1*, Kelly Zullo, MS1*, Michael Mangone, PhD1*, Jennifer E Amengual, MD1, Changchun Deng, MD, PhD2 and Owen A. O'Connor, MD, PhD1

1Center for Lymphoid Malignancies, Department of Medicine, Columbia University Medical Center, New York, NY
2Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY

Baohua Sun, MD, PhD1, Warren Fiskus, Ph.D1, Dyana T Saenz1*, Stephanie Krieger1*, Liang Zhang, MD, PhD2, Simrit Parmar, MD3, Michael Wang, MD4 and Kapil N. Bhalla, MD5

1Department of Leukemia, MD Anderson Cancer Center, Houston, TX
2Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Seongseok Yun, MD, PhD1*, Nicole D. Vincelette2*, Katherine L. B. Knorr, PhD3, Luciana L. Almada, PhD4*, Paula A. Schneider4*, Kevin L. Peterson, PhD4*, Karen S. Flatten4*, Allan D. Hess, PhD5, B. Douglas Smith, MD6, Judith E. Karp, MD7, Martin E. Fernandez-Zapico, MD4 and Scott H. Kaufmann, MD, PhD8

1University of Arizona, Tucson, AZ
2Mayo Graduate School, Rochester, MN
3Mayo Medical and Graduate Schools, Rochester, MN
4Mayo Clinic, Rochester, MN
5Department of Oncology, Division of Hematological Malignancies, Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore, MD
6Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
7Johns Hopkins University, Baltimore, MD
8Oncology Research, Mayo Clinic, Rochester, MN

Greg P. Coffey, PhD1*, Jiajia Feng, MD1*, Glenn Michelson, MD1*, Janet Leads, PhD1*, John T. Curnutte, MD, PhD2, Anjali Pandey, PhD1* and Pamela B. Conley, PhD2

1Portola Pharmaceuticals Inc, South San Francisco, CA
2Portola Pharmaceuticals, Inc., South San Francisco, CA

Sarah Meadows*, Sorensen Rick*, Yahiaoui Anella*, Jia Liu, PhD*, Li Li, PhD, Peng Yue, PhD*, Christophe Queva, PhD and Stacey Tannheimer, PhD*

Gilead Sciences, Foster City, CA

Jennifer E Amengual, MD1, Maximilian Lombardo1*, Kelly M Zullo1*, Paul M. Johannet, BA2, Sathyen A Prabhu1*, Gonzalez Yulissa1*, Luigi Scotto, PhD3*, Ying Wei4*, Jimmy Duong4* and Owen A. O'Connor, MD, PhD3

1Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY
2Stanford University, Stanford, CA
3Center for Lymphoid Malignancies, Department of Medicine, Columbia University Medical Center, New York, NY
4Department of Biostatistics, Mailman School of Public Health, Columbia University Medical Center, New York, NY

Eugen Dhimolea, PhD1*, Emily King1*, Michal Sheffer, PhD1*, Yiguo Hu, MD, PhD1*, Pallavi P. Awate1*, Subhashis Sarkar, PhD1*, Geoffrey M. Matthews, PhD1*, Megan Murnane2*, Megan A. Bariteau, BSc1*, Blake T. Aftab, PhD2 and Constantine S Mitsiades, MD, PhD1

1Dept. of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
2Dept. of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA

Sara Redaelli, PhD1*, Monica Ceccon, PhD2*, Alessandra Pirola, MSc1*, Marco Peronaci, MSc2*, Carlo Gambacorti-Passerini, MD1,3 and Luca Mologni, PhD2*

1Dept. of Health Sciences, University of Milano-Bicocca, Monza, Italy
2Dept. of Health Sciences, University of Milano Bicocca, Monza, Italy
3Hematology and Clinical Research Unit, San Gerardo Hospital, Monza, Italy

Samantha N. Reiss, PharmD1*, Larry W. Buie, PharmD, BCOP1*, Nelly G. Adel, PharmD, BCOP, BCPS1*, Debra A. Goldman, MS2*, Sean Devlin, PhD2* and Dan Douer, MD3

1Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
3Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Niels Franke, MD1*, Gertjan J.L. Kaspers, MD, PhD1, Yehuda G Assaraf, PhD2*, Johan Van Meerloo, MSc1*, Denise Niewerth, PhD1*, Terzah M. Horton, MD, PhD3, Wee Joo Chng, MD, PhD4,5, Chonglei Bi, B.S4*, Rene X. Menezes, PhD6*, Renée J. Musters, PhD7*, Pino J. Poddighe, PhD8*, Floortje Kessler9*, Serge Smeets, PhD10*, Bauke Ylstra, PhD11*, Sonja Zweegman, MD, PhD12, Gerrit Jansen, PhD13* and Jacqueline Cloos, PhD1,9*

1Department of Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, Netherlands
2Department of Biology, The Fred Wyszkowski Cancer Research Laboratory, Technion-Israel Institute of Technology, Haifa, Israel
3Pediatrics, Hematology/Oncology, Baylor College of Medicine, Houston, TX
4Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore
5Department of Haematology-Oncology, National University Cancer Institute of Singapore, National University Health System, Singapore, Singapore
6Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, Netherlands
7Department of Physiology, VU University Medical Center, Amsterdam, Netherlands
8Department of Genetics, VU University Medical Center, Amsterdam, Netherlands
9Department of Hematology, VU University Medical Center, Amsterdam, Netherlands
10Novartis Pharma, Arnhem, Netherlands
11Department of Pathology, VU University Medical Center, Amsterdam, Netherlands
12Department of Hematology, VUMC, Amsterdam, Netherlands
13Dept of Rheumatology, Amsterdam Rheumatology and immunology Center, Amsterdam, Netherlands

*signifies non-member of ASH